Board of Trustees Archives - American Board of Pathology

ABPath Announces 2026 Board of Trustees and Executive Committee

Bonnie Woodworth — Wed, 17 Dec 2025 12:50:43 +0000

Pictured from left to right -Back Row : Jason Jarzembowski, MD, PhD; James R. Cook, MD; PhD; Matthew J. Wasco, MD; Dylan V. Miller, MD; Jeffrey D. Goldstein, MD; Gary W. Procop, MD, MS, MEd
Front Row: Julie D. Kingery, MD; Mark K. Fung, MD, PhD; Kathleen G. Beavis, MD; Mohiedean Ghofrani, MD, MBA; Barbara A. Sampson, MD, PhD
Not Pictured: Jennifer Laudadio, MD; Ritu Nayar, MD; Javarro Russell, PhD

TAMPA, Fla., (December 17, 2025) – The American Board of Pathology (ABPath), a member board of the American Board of Medical Specialties, is pleased to announce the Board of Trustees and election of officers for 2026.

The newly elected Executive Committee includes:

President – Kathleen G. Beavis, MD, Chicago, IL

Vice President – Mark K. Fung, MD, PhD, Burlington, VT

Secretary – Matthew J. Wasco, MD, Ann Arbor, MI

Treasurer – Jennifer Laudadio, MD, Little Rock, AR

Immediate Past President – Mohiedean Ghofrani, MD, MBA, Vancouver, WA

Congratulations to the following Trustees who were re-elected to additional terms as Trustees:

James R. Cook, MD, PhD, to a second term

Mohiedean Ghofrani, MD, MBA, to a fourth term

Julie D. Kingery, MD, to a second term

Jennifer Laudadio, MD, to a second term

Barbara A. Sampson, MD, PhD, to a fourth term

In addition to the officers, the Trustees of the American Board of Pathology are:

James R. Cook, MD, PhD, Cleveland, OH

Jeffrey D. Goldstein, MD, Los Angeles, CA

Jason Jarzembowski, MD, PhD, Milwaukee, WI

Julie D. Kingery, MD, Gainesville, FL

Dylan V. Miller, MD, Salt Lake City, UT

Ritu Nayar, MD, Chicago, IL

Javarro Russell, PhD, Richmond, VA

Barbara A. Sampson, MD, PhD, New York, NY

ABPath extends a heartfelt thank you to Edward R. Ashwood, MD, who completed his term as a Trustee in 2025. Dr. Ashwood’s dedication and expertise have greatly contributed to advancing board certification in pathology. We are grateful for his leadership and lasting contributions to ABPath and the profession.

We appreciate our Trustees’ continued support, dedication, and willingness to serve as leaders in the profession of pathology, enabling the Board to fulfill its mission of serving the public and promoting excellence in the practice of pathology.

About the American Board of Pathology

The mission of the American Board of Pathology, as a member of the American Board of Medical Specialties, is to serve the public and advance the profession of pathology by setting certification standards and promoting lifelong competency of pathologists. Founded in 1936, the ABPath accomplishes this mission by establishing certification and continuing certification standards and assessing the qualifications of those seeking to obtain voluntary certification in the specialty of pathology. For more information visit abpath.org or call (813) 286-2444.

The post ABPath Announces 2026 Board of Trustees and Executive Committee appeared first on American Board of Pathology.

In Memoriam: Former ABPath Trustee and President Deborah E. Powell, MD

Bonnie Woodworth — Fri, 07 Nov 2025 16:37:30 +0000

In Memoriam

Deborah E. Powell, MD

1939 – 2025

November 7, 2025 – The American Board of Pathology (ABPath) is very saddened to hear about the loss of Dr. Deborah E. Powell, former Trustee and President of the ABPath, who passed away on October 30th, 2025, at the age of 85.

Dr. Powell served as an ABPath Trustee from 1995 to 2006 and held several leadership positions, including Treasurer (2001–2002), Vice President (2003), and President (2004). During her tenure, she brought to the Board her deep expertise in medical education and thoughtful leadership, helping to inform ABPath’s efforts to uphold excellence in board certification. She remained a respected voice and supporter of ABPath, returning on occasion to share her insight on competency-based medical education and its role in shaping the future of physician training.

A pioneering medical educator and visionary leader, Dr. Powell was known nationally for her transformative impact on medical education. She served as Dean of the University of Minnesota Medical School from 2002 to 2009. During that time she introduced the Flexible MD Program, allowing students to individualize the pace of their medical training, and launched the Education in Pediatrics Across the Continuum (EPAC) initiative, a project she considered her proudest professional achievement and a national model for competency-based education. Her academic career also included leadership roles at the University of Kentucky, where she chaired the Department of Pathology and Laboratory Medicine, and at the University of Kansas, where she served as Executive Dean and Vice Chancellor for Clinical Affairs.

Dr. Powell’s influence extended across the profession through her service to major national organizations, including the Association of American Medical Colleges and the Accreditation Council for Graduate Medical Education. She was elected to the National Academy of Medicine and received numerous honors recognizing her vision, mentorship, and lifelong commitment to advancing medical education and patient care.

Remembered for her intellect, warmth, and integrity, Dr. Powell was both an inspiring leader and a generous mentor. She will be long remembered for the leadership, humanity, and forward-thinking spirit she brought to pathology and medical education.

We extend our condolences to Dr. Powell’s family, colleagues, and all who had the privilege of working with her.

The post In Memoriam: Former ABPath Trustee and President Deborah E. Powell, MD appeared first on American Board of Pathology.

American Board of Pathology Elects Jason Jarzembowski, MD, PhD, to Board of Trustees

Bonnie Woodworth — Wed, 10 Sep 2025 14:37:33 +0000

TAMPA, Fla (September 10, 2025)

The American Board of Pathology (ABPath) is pleased to announce that Dr. Jason Jarzembowski has been elected to its Board of Trustees, with a term beginning January 1, 2026.

Dr. Jarzembowski is Vice Chair for Pediatric Pathology and Professor of Pathology at the Medical College of Wisconsin and Chief Executive Officer of Children’s Specialty Group. Children’s Specialty Group is a not-for-profit, multi-specialty academic group practice of the Medical College of Wisconsin and Children’s Wisconsin with nearly 500 pediatric specialty physicians and more than 300 pediatric advanced practice providers. Dr. Jarzembowski will begin serving as a Trustee of the ABPath in 2026 and currently serves on the Anatomic Pathology Certlink Test Development and Advisory Committee. He earned his doctorate in Molecular and Cellular Pathology at the University of Wisconsin–Madison and his medical degree with research honors at the Medical College of Wisconsin. He completed his residency in anatomic and clinical pathology at the University of Michigan, followed by a fellowship in pediatric pathology at St. Louis Children’s Hospital and Washington University in St. Louis. Dr. Jarzembowski is board certified in Anatomic and Clinical Pathology and Pediatric Pathology and is participating in the Continuing Certification Program.

Dr. Jarzembowski is Associate Editor of the journals Pediatric and Developmental Pathology and American Journal of Clinical Pathology. He also serves on the editorial board of the Archives of Pathology & Laboratory Medicine and co-authored the College of American Pathologists cancer reporting protocols for neuroblastoma. He has chaired the Children’s Oncology Group’s Pathology Committee since 2016 and was an expert editor for the inaugural WHO Classification of Tumours: Paediatric Tumours. He has previously served on the board of directors for the Society for Pediatric Pathology and chaired both its Research and the Informatics and Communication Committees.

ABPath’s Board of Trustees is made up of 12 board-certified pathologist members and one public member. Each member is highly esteemed and accomplished in their respective fields and/or subspecialties. Trustees are elected for 3-year terms and may serve up to four terms.

About the American Board of Pathology

The post American Board of Pathology Elects Jason Jarzembowski, MD, PhD, to Board of Trustees appeared first on American Board of Pathology.

ABPath Announces 2025 Board of Trustees and Executive Committee

Bonnie Woodworth — Wed, 29 Jan 2025 16:03:14 +0000

Pictured from left to right: Back row—Javarro Russell, Ph.D.; Dylan V. Miller, M.D.; Jeffrey D. Goldstein, M.D.; Matthew J. Wasco, M.D.; Edward R. Ashwood, M.D.; Gary W. Procop, M.D., M.S., M.Ed.; James R. Cook, M.D., Ph.D.
Front row—Ritu Nayar, M.D.; Mark K. Fung, M.D., Ph.D.;
Barbara A. Sampson, M.D., Ph.D.; Mohiedean Ghofrani, M.D., M.B.A.; Kathleen G. Beavis, M.D.; Julie D. Kingery, M.D.; Jennifer Laudadio, M.D.

TAMPA, Fla, (January 29, 2025 )- The American Board of Pathology (ABPath), a member board of the American Board of Medical Specialties, is pleased to announce the Board of Trustees and the election of officers for 2025.

The newly elected Executive Committee includes:

President – Mohiedean Ghofrani, MD, MBA, Vancouver, WA

Vice President – Kathleen G. Beavis, MD, Chicago, IL

Secretary – Matthew J. Wasco, MD, Ann Arbor, MI

Treasurer – Mark K. Fung, MD, PhD, Burlington, VT

Immediate Past President – Barbara A. Sampson, MD, PhD, New York, NY

Congratulations to the following Trustees who were re-elected to additional terms as Trustees:

Kathleen G. Beavis, MD to a 3rd term

Jeffrey D. Goldstein, MD to a 4th term

Ritu Nayar, MD to a 4th term

In addition to the officers, the Trustees of the American Board of Pathology are:

Edward R. Ashwood, MD, Aurora, CO

James R. Cook, MD, PhD, Cleveland, OH

Jeffrey D. Goldstein, MD, Los Angeles, CA

Julie D. Kingery, MD, Gainesville, FL

Jennifer Laudadio, MD, Little Rock, AR

Dylan Miller, MD, Salt Lake City, UT

Ritu Nayar, MD, Chicago, Il

Javarro Russell, PhD, Richmond, VA

ABPath extends a heartfelt thank you to Eric Glassy, MD, who completed his term as a Trustee in 2024. Dr. Glassy’s expertise in digital pathology and emerging technologies has greatly contributed to advancing board certification in pathology.

For a complete list of Trustees and their biographical information visit https://abpath.org/board-of-trustees/.

About the American Board of Pathology

The post ABPath Announces 2025 Board of Trustees and Executive Committee appeared first on American Board of Pathology.

ABPath Welcomes New Board Member Dylan V. Miller, MD

Bonnie Woodworth — Tue, 27 Aug 2024 13:47:14 +0000

TAMPA, Fla, ( August 27, 2024)- The Trustees of the American Board of Pathology (ABPath) are pleased to announce the election of Dr. Dylan Miller to serve on the Board of Trustees with a term beginning on January 1, 2025.

Dr. Dylan Miller is a Professor of Pathology at the University of Utah School of Medicine and the Director of Anatomic Pathology at Intermountain Central Laboratory, which serves Intermountain Healthcare’s statewide hospital system. He practices with a private group at Intermountain Medical Center in Salt Lake City. Dr. Miller earned his MD from the University of Utah School of Medicine and completed his residency and surgical pathology fellowship at the Mayo Clinic in Rochester, MN. Dr. Miller is board certified in Anatomic and Clinical Pathology and is participating in the Continuing Certification Program.

Dr. Miller is widely published, particularly in cardiovascular, transplant, and autopsy pathology. He has authored numerous book chapters and co-edited textbooks on cardiovascular and hospital autopsy pathology. He currently serves as President of the Utah Society for Pathology, Chair of the CAP Immunohistochemistry Committee, and previously chaired the CAP Autopsy Committee. He is also the Secretary of the Society for Cardiovascular Pathology.

The ABPath’s Board of Trustees is made up of 12 board-certified pathologist members and one public member. Each member is highly esteemed and accomplished in their respective fields and/or subspecialty. Trustees are elected for 3-year terms and may serve up to four terms.

About the American Board of Pathology

The post ABPath Welcomes New Board Member Dylan V. Miller, MD appeared first on American Board of Pathology.

In Memoriam: Former ABPath Trustee William Woodard McLendon, MD

Bonnie Woodworth — Tue, 06 Aug 2024 15:25:50 +0000

In Memoriam

William Woodard McLendon, MD

October 29, 1930 – June 8, 2024

August 6, 2024 – William Woodard “Bill” McLendon, MD, former Trustee and Treasurer of the American Board of Pathology (ABPath) passed away on June 8, 2024, at the age of 93.

Dr. McClendon served as a Trustee for the ABPath from 1979-1984 and made many contributions to advancing the profession of pathology and board certification through his work on the Board. Dr. McLendon served as Treasurer of the ABPath in 1983-84 and also served as Chair of the Blood Banking and Radioisotopic Pathology Test Development and Advisory Committees.

Dr. McLendon had a distinguished career in pathology and laboratory medicine. He graduated medical school from the University of North Carolina (UNC)-Chapel Hill in 1956, and from 1956 to 1961 he had his residency education at Columbia-Presbyterian Medical Center in New York City and then at UNC in Chapel Hill.

In 1973, Dr. McLendon served as Professor of Pathology and Director of the Division of Laboratory Medicine in the UNC School of Medicine and as Director of the Hospital Laboratories at UNC Hospitals. After consolidating the various clinical laboratories into one hospital department, his group in 1984 implemented the hospital’s first computerized clinical information system, which was an earlier version of today’s electronic medical records system. These laboratories have also been leaders in applying the rapidly evolving techniques of DNA research for patient care. Upon his retirement in 1995, the hospital laboratories were named the William W. McLendon Clinical Laboratories, and the Division of Laboratory Medicine and the century-old Department of Pathology were consolidated into the current UNC Department of Pathology and Laboratory Medicine.

In addition to his work with the ABPath, He was nationally active as an editor of the Archives of Pathology and Laboratory Medicine for 13 years and as a member of the editorial board of the Journal of The American Medical Association (JAMA). In 1993 he was a co-editor of a special issue of JAMA celebrating the 40th anniversary of the discovery of the DNA double helix by Watson and Crick and introducing practicing physicians to the evolving personalized medicine made possible by that discovery. He served as president of the Academy of Clinical Laboratory Physicians and Scientists and received the Academy’s Gerald T. Evans Award. He received the College of American Pathologists’ National Pathologist of the Year Award in 1997. He received the North Carolina Order of the Long Leaf Pine Award in 2012 and the Distinguished Faculty Award of the UNC School of Medicine and Medical Alumni Association in 2013.

In lieu of flowers, the family requests contributions to the UNC Health Foundation. Please include a note indicating the contribution is in memory of Dr. William W. McLendon and designated for the L. P. McLendon Scholarship Fund (349359). Checks may be mailed to the Office of University Development, PO Box 309, Chapel Hill, NC 27514. Online donations can be made at https://give.unc.edu/hfdonate?p=MCLE.

The post In Memoriam: Former ABPath Trustee William Woodard McLendon, MD appeared first on American Board of Pathology.

ABPath Welcomes New Public Board Member Javarro Russell, PhD

Bonnie Woodworth — Thu, 07 Sep 2023 14:16:01 +0000

TAMPA, Fla, (September 7, 2023)- The Trustees of the American Board of Pathology (ABPath) are pleased to announce the election of Javarro Russell, PhD as the new public member to the Board of Trustees with a term beginning on January 1, 2024. Dr. Russell brings a wealth of experience in exam development and administration, making him a valuable addition to the Board.

Dr. Russell currently serves as the Senior Director for the Admissions Testing Service at the Association of American Medical Colleges (AAMC). In this distinguished role, he oversees the strategic direction of all aspects of the Medical College Admission Test (MCAT) and MCAT Prep portfolio. These areas include business operations, research & development, test security, communications, and derivative products. The MCAT testing program is instrumental in supporting the admissions process at over 150 medical schools and more than 80 thousand examinees annually.

Prior to his tenure at the AAMC, Dr. Russell has served in leadership roles at the National Board of Medical Examiners and the Educational Testing Service. His service to these organizations focused on measurement and assessment design issues in higher education, as well as business development. He has also assisted institutions in identifying solutions for assessing and measuring student learning outcomes, such as content knowledge, critical thinking and collaborative problem-solving.

Dr. Russell has previously served as the Board Member and President of the Northeastern Educational Research Association. He has also held several committee leadership roles for the American Association of Educational Research.

He holds two degrees from Norfolk State University, a Historically Black College and University. His PhD in Assessment and Measurement is from James Madison University.

The ABPath’s Board of Trustees is made up of 12 board-certified pathologist members and one public member. The public member is a non-physician member who will advocate for community and public interests, and provide a public perspective for discussion of issues and decisions made by the Board of Trustees. Each member is highly esteemed and accomplished in their respective fields and/or subspecialty. Trustees are elected for 3-year terms.

About the American Board of Pathology

The post ABPath Welcomes New Public Board Member Javarro Russell, PhD appeared first on American Board of Pathology.

Susan Fuhrman, MD; Karen Kaul, MD, PhD; and Steven Swerdlow, MD Honored as Life Trustees

Bonnie Woodworth — Wed, 23 Aug 2023 14:07:44 +0000

TAMPA, Fla, (August 23, 2023) – The American Board of Pathology (ABPath) recently honored Susan Fuhrman, MD; Karen Kaul, MD, PhD; and Steven Swerdlow, MD as Life Trustees for their many years of dedicated service and contributions to the Board. They were awarded the Life Trustee plaques by Dr. Ritu Nayar, President at the Summer Board of Trustees meeting.

Susan Fuhrman, MD was a Trustee from 2011-2022 and served as President in 2019 and Vice President in 2018. Dr. Fuhrman is the former System Director for Pathology and Laboratory Services at OhioHealth, a large not-for-profit integrated healthcare delivery system based in Columbus Ohio. She was the President and CEO of CORPath, a professional practice LLC that provides pathology services to OhioHealth hospitals. Dr. Fuhrman earned her medical degree from the University of Michigan and completed her residency in pathology at the University of Minnesota Medical School. Dr. Fuhrman is board certified in Anatomic and Clinical Pathology and Chemical Pathology and participates in the Continuing Certification Program.

Dr. Fuhrman’s responsibilities at the ABPath included Chairperson, Test Development and Advisory Committee for Management and Informatics and Chairperson, Test Development and Advisory Committee for ABPath CertLink Clinical Pathology.

Karen Kaul, MD, PhD was a Trustee of the ABPath from 2011-2022 and was President in 2018 and Vice President in 2017. Dr. Kaul is the Chair of the Department of Pathology and Laboratory Medicine at NorthShore University HealthSystem in Evanston, Illinois, and a Clinical Professor of Pathology at the University of Chicago Pritzker School of Medicine. She earned her medical and graduate degrees from Northwestern University Feinberg School of Medicine and completed her residency in pathology at Northwestern Memorial Hospital. Dr. Kaul is board certified in Anatomic Pathology and Molecular Genetic Pathology and participates in the Continuing Certification Program.

Dr. Kaul’s responsibilities at the ABPath included Chairperson, Test Development & Advisory Committee for Molecular Genetics.

Steven Swerdlow, MD was a Trustee of the ABPath from 2011-2022 and served as President in 2020 and Vice President in 2019. Dr. Swerdlow is a former Professor of Pathology and Director, Division of Hematopathology at the University of Pittsburgh School of Medicine. He earned his medical degree from Harvard Medical School and completed a residency in pathology at Beth Israel Hospital in Boston, followed by a fellowship in hematopathology with Dr. R. D. Collins at Vanderbilt University and a research fellowship at St. Bartholomew’s Hospital, London. Dr. Swerdlow is board certified in Anatomic and Clinical Pathology and participates in the Continuing Certification Program.

Dr. Swerdlow’s responsibilities at the ABPath included Chairperson, Test Development and Advisory Committee for Hematopathology; Chairperson, Bylaws Committee; and Chairperson, Committee on Examinations.

About the American Board of Pathology

The post Susan Fuhrman, MD; Karen Kaul, MD, PhD; and Steven Swerdlow, MD Honored as Life Trustees appeared first on American Board of Pathology.